Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Innovations in translational sex and gender-sensitive tobacco research.

McKee SA, Weinberger AH.

Nicotine Tob Res. 2015 Apr;17(4):379-81. doi: 10.1093/ntr/ntu335. Epub 2015 Mar 11. No abstract available.

2.

Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice.

Aubin HJ, Luquiens A, Berlin I.

Br J Clin Pharmacol. 2014 Feb;77(2):324-36. doi: 10.1111/bcp.12116. Review.

3.

Dietary intake after smoking cessation among weight-concerned women smokers.

Levine MD, Cheng Y, Kalarchian MA, Perkins KA, Marcus MD.

Psychol Addict Behav. 2012 Dec;26(4):969-73. doi: 10.1037/a0028948. Epub 2012 Jul 16.

4.

The role of gender in a smoking cessation intervention: a cluster randomized clinical trial.

Puente D, Cabezas C, Rodriguez-Blanco T, Fernández-Alonso C, Cebrian T, Torrecilla M, Clemente L, Martín C; ISTAPS study group investigators.

BMC Public Health. 2011 May 23;11:369. doi: 10.1186/1471-2458-11-369.

5.

Effect of bupropion treatment on brain activation induced by cigarette-related cues in smokers.

Culbertson CS, Bramen J, Cohen MS, London ED, Olmstead RE, Gan JJ, Costello MR, Shulenberger S, Mandelkern MA, Brody AL.

Arch Gen Psychiatry. 2011 May;68(5):505-15. doi: 10.1001/archgenpsychiatry.2010.193. Epub 2011 Jan 3.

6.

Do point prevalence and prolonged abstinence measures produce similar results in smoking cessation studies? A systematic review.

Hughes JR, Carpenter MJ, Naud S.

Nicotine Tob Res. 2010 Jul;12(7):756-62. doi: 10.1093/ntr/ntq078. Epub 2010 May 26. Review.

7.

Efficacy of pharmacotherapies for short-term smoking abstinance: a systematic review and meta-analysis.

Mills EJ, Wu P, Spurden D, Ebbert JO, Wilson K.

Harm Reduct J. 2009 Sep 18;6:25. doi: 10.1186/1477-7517-6-25.

8.

The association among depressive symptoms, smoking status and antidepressant use in cardiac outpatients.

Gravely-Witte S, Stewart DE, Suskin N, Grace SL.

J Behav Med. 2009 Oct;32(5):478-90. doi: 10.1007/s10865-009-9218-3. Epub 2009 Jun 6.

9.

Risk factors for treatment failure in smokers: relationship to alcohol use and to lifetime history of an alcohol use disorder.

Leeman RF, McKee SA, Toll BA, Krishnan-Sarin S, Cooney JL, Makuch RW, O'Malley SS.

Nicotine Tob Res. 2008 Dec;10(12):1793-809. doi: 10.1080/14622200802443742. Erratum in: Nicotine Tob Res. 2009 Sep;11(9):1126.

10.

Comparison of expired carbon monoxide and plasma cotinine as markers of cigarette abstinence.

Jatlow P, Toll BA, Leary V, Krishnan-Sarin S, O'Malley SS.

Drug Alcohol Depend. 2008 Dec 1;98(3):203-9. doi: 10.1016/j.drugalcdep.2008.05.013. Epub 2008 Jul 22.

11.

Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials.

Eisenberg MJ, Filion KB, Yavin D, Bélisle P, Mottillo S, Joseph L, Gervais A, O'Loughlin J, Paradis G, Rinfret S, Pilote L.

CMAJ. 2008 Jul 15;179(2):135-44. doi: 10.1503/cmaj.070256. Review. Erratum in: CMAJ. 2008 Oct 7;179(8):802.

12.

The use of bupropion SR in cigarette smoking cessation.

Wilkes S.

Int J Chron Obstruct Pulmon Dis. 2008;3(1):45-53. Review.

13.

A test of motivational plus nicotine replacement interventions for HIV positive smokers.

Ingersoll KS, Cropsey KL, Heckman CJ.

AIDS Behav. 2009 Jun;13(3):545-54. Epub 2007 Dec 8.

14.

Bupropion and nicotine patch as smoking cessation aids in alcoholics.

Grant KM, Kelley SS, Smith LM, Agrawal S, Meyer JR, Romberger DJ.

Alcohol. 2007 Aug;41(5):381-91.

15.
16.

Pragmatic, observational study of bupropion treatment for smoking cessation in general practice.

Wilkes S, Evans A, Henderson M, Gibson J.

Postgrad Med J. 2005 Nov;81(961):719-22.

Supplemental Content

Support Center